Overview

* Cardlytics ( CDLX ) Q3 revenue declines 22% yr/yr, missing analyst expectations

* Adjusted EBITDA for Q3 improves to $3.2 mln from $(1.8) mln last year

* Company reports net cash provided by operating activities of $1.8 mln

Outlook

* Cardlytics expects Q4 2025 revenue between $51.1 mln and $59.1 mln

* Company forecasts Q4 2025 Billings between $86.0 mln and $96.0 mln

* Cardlytics projects Q4 2025 Adjusted EBITDA between $0.9 mln and $7.9 mln

Result Drivers

* STRATEGIC INITIATIVES - CEO Amit Gupta states the company is taking decisive actions to reset business and improve financial health

* USER GROWTH - Cardlytics ( CDLX ) reports 21% increase in monthly qualified users yr/yr, indicating growth in user engagement

* FOCUS ON FUNDAMENTALS - Co prioritizes initiatives that build on fundamental strengths and areas where it can win

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q3 Miss $52.03 $54.30

Revenue mln mln (3

Analysts

)

Q3 EPS -$1.36

Q3 Net -$72.67

Income mln

Q3 $89.19

Billings mln

Analyst Coverage

* The current average analyst rating on the shares is "hold" and the breakdown of recommendations is no "strong buy" or "buy", 4 "hold" and 1 "sell" or "strong sell"

* The average consensus recommendation for the software peer group is "buy."

* Wall Street's median 12-month price target for Cardlytics Inc ( CDLX ) is $1.50, about 15.7% below its November 4 closing price of $1.74

Press Release:

For questions concerning the data in this report, contact [email protected]. For any other questions or feedback, contact .

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)